Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Clinical Data Standards-Setting Likely To Run Longer Than Five Years

Executive Summary

Agency’s goal of setting standards for clinical data in 57 therapeutic areas in five years looks unlikely to be met, according to the timelines given by members of the Coalition For Accelerating Standards and Therapies.

You may also be interested in...



FDA Therapeutic Area Standards Would Have To Clear Industry Testing

Validation rules for standardized clinical trial data terminology could allow sponsors to check their data in the same way FDA does.

FDA/Industry Interactions Might Get Revised Rules Of Road After Opioid Publicity

Sen. Manchin calls for congressional investigation of “pay to play” allegations; FDA maintains the meetings with industry were for scientific, not regulatory purposes, but the agency is looking into the matter.

Deals Of The Week: Forest/Adamas, Colby/MannKind, Pernix/Cypress/Hawthorn

Building on the 10-pharma clinical development problem-solving initiative launched in September, J&J, Merck and Lilly are spearheading a databank that will share information on clinical trial sites and investigators, with a primary goal of avoiding redundancy in paperwork and training.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS054900

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel